NISA INVESTMENT ADVISORS, LLC - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 150 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$37,431
-24.2%
2,886
+2.1%
0.00%
Q1 2024$49,359
+85.5%
2,8270.0%0.00%
Q4 2023$26,602
+336.2%
2,827
+417.8%
0.00%
Q3 2023$6,099
-44.1%
546
+7.1%
0.00%
Q2 2023$10,914
+155814.3%
510
+188.1%
0.00%
Q1 2023$7
-83.7%
177
-80.9%
0.00%
Q4 2022$43
-99.9%
927
-1.0%
0.00%
Q3 2022$42,000
-26.3%
936
-22.5%
0.00%
Q2 2022$57,000
+72.7%
1,207
+164.1%
0.00%
Q1 2022$33,000
-63.7%
457
-70.2%
0.00%
-100.0%
Q4 2021$91,000
-63.7%
1,534
-65.3%
0.00%
-50.0%
Q3 2021$251,000
-11.3%
4,420
-31.3%
0.00%0.0%
Q2 2021$283,000
-10.7%
6,4340.0%0.00%0.0%
Q1 2021$317,000
+17.0%
6,4340.0%0.00%0.0%
Q4 2020$271,000
+61.3%
6,434
+75.2%
0.00%
+100.0%
Q3 2020$168,000
+425.0%
3,672
+473.8%
0.00%
Q2 2020$32,000
+357.1%
640
+357.1%
0.00%
Q1 2020$7,000
+16.7%
140
+55.6%
0.00%
Q4 2019$6,000
+20.0%
900.0%0.00%
Q3 2019$5,000
-37.5%
900.0%0.00%
Q2 2019$8,000
-11.1%
900.0%0.00%
Q1 2019$9,000
+50.0%
900.0%0.00%
Q4 2018$6,000
-25.0%
900.0%0.00%
Q3 2018$8,000900.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 1,599,109$63,277,0008.68%
SENZAR ASSET MANAGEMENT, LLC 566,903$22,432,0006.58%
Sarissa Capital Management LP 105,000$4,155,0001.60%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 136,637$5,407,0001.41%
RA Capital Management 250,000$9,893,0001.17%
BENNETT LAWRENCE MANAGEMENT L L C/NY 110,515$4,373,0000.99%
Ghost Tree Capital, LLC 35,000$1,385,0000.75%
WALL STREET ASSOCIATES 159,100$6,296,0000.65%
BAILARD, INC. 91,500$3,621,0000.56%
EAM Investors, LLC 62,768$2,484,0000.50%
View complete list of ENANTA PHARMACEUTICALS INC shareholders